FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103459003> ?p ?o ?g. }

• W2103459003 endingPage "3082" @default.
• W2103459003 startingPage "3064" @default.
• W2103459003 abstract "Organometallic ruthenium(II) arene anticancer complexes of the type [(eta(6)-arene)Ru(II)(en)Cl][PF(6)] (en = ethylenediamine) specifically target guanine bases of DNA oligomers and form monofunctional adducts (Morris, R., et al. J. Med. Chem. 2001). We have determined the structures of monofunctional adducts of the piano-stool complexes [(eta(6)-Bip)Ru(II)(en)Cl][PF(6)] (1, Bip = biphenyl), [(eta(6)-THA)Ru(II)(en)Cl][PF(6)] (2, THA = 5,8,9,10-tetrahydroanthracene), and [(eta(6)-DHA)Ru(II)(en)Cl][PF(6)] (3, DHA = 9,10-dihydroanthracene) with guanine derivatives, in the solid state by X-ray crystallography, and in solution using 2D [(1)H,(1)H] NOESY and [(1)H,(15)N] HSQC NMR methods. Strong pi-pi arene-nucleobase stacking is present in the crystal structures of [(eta(6)-C(14)H(14))Ru(en)(9EtG-N7)][PF(6)](2).(MeOH) (6) and [(eta(6)-C(14)H(12))Ru(en)(9EtG-N7)][PF(6)](2).2(MeOH) (7) (9EtG = 9-ethylguanine). The anthracene outer ring (C) stacks over the purine base at distances of 3.45 A for 6 and 3.31 A for 7, with dihedral angles of 3.3 degrees and 3.1 degrees, respectively. In the crystal structure of [(eta(6)-biphenyl)Ru(en)(9EtG-N7)][PF(6)](2).(MeOH) (4), there is intermolecular stacking between the pendant phenyl ring and the purine six-membered ring at a distance of 4.0 A (dihedral angle 4.5 degrees). This stacking stabilizes a cyclic tetramer structure in the unit cell. The guanosine (Guo) adduct [(eta(6)-biphenyl)Ru(en)(Guo-N7)][PF(6)](2).3.75(H(2)O) (5) exhibits intramolecular stacking of the pendant phenyl ring with the purine five-membered ring (3.8 A, 23.8 degrees) and intermolecular stacking of the purine six-membered ring with an adjacent pendant phenyl ring (4.2 A, 23.0 degrees). These occur alternately giving a columnar-type structure. A syn orientation of arene and purine is present in the crystal structures 5, 6, and 7, while the orientation is anti for 4. However, in solution, a syn orientation predominates for all the biphenyl adducts 4, 5, and the guanosine 5'-monophosphate (5'-GMP) adduct 8 [(eta(6)-biphenyl)Ru(II)(en)(5'-GMP-N7)], as revealed by NMR NOE studies. The predominance of the syn orientation both in the solid state and in solution can be attributed to hydrophobic interactions between the arene and purine rings. There are significant reorientations and conformational changes of the arene ligands in [(eta(6)-arene)Ru(II)(en)(G-N7)] complexes in the solid state, with respect to those of the parent chloro-complexes [(eta(6)-arene)Ru(II)(en)Cl](+). The arene ligands have flexibility through rotation around the arene-Ru pi-bonds, propeller twisting for Bip, and hinge-bending for THA and DHA. Thus propeller twisting of Bip decreases by ca. 10 degrees so as to maximize intra- or intermolecular stacking with the purine ring, and stacking of THA and DHA with the purine is optimized when their tricyclic ring systems are bent by ca. 30 degrees, which involves increased bending of THA and a flattening of DHA. This flexibility makes simultaneous arene-base stacking and N7-covalent binding compatible. Strong stereospecific intramolecular H-bonding between an en NH proton oriented away from the arene (en NH(d)) and the C6 carbonyl of G (G O6) is present in the crystal structures of 4, 5, 6, and 7 (average N...O distance 2.8 A, N-H...O angle 163 degrees ). NMR studies of the 5'-GMP adduct 8 provided evidence that en NH(d) protons are involved in strong H-bonding with the 5'-phosphate and O6 of 5'-GMP. The strong H-bonding from G O6 to en NH(d) protons partly accounts for the high preference for binding of [(eta(6)-arene)Ru(II)en](2+) to G versus A (adenine). These studies suggest that simultaneous covalent coordination, intercalation, and stereospecific H-bonding can be incorporated into Ru(II) arene complexes to optimize their DNA recognition behavior, and as potential drug design features." @default.
• W2103459003 created "2016-06-24" @default.
• W2103459003 creator A5020864776 @default.
• W2103459003 creator A5050976890 @default.
• W2103459003 creator A5056323219 @default.
• W2103459003 creator A5060244445 @default.
• W2103459003 creator A5071855899 @default.
• W2103459003 creator A5088303429 @default.
• W2103459003 date "2002-03-01" @default.
• W2103459003 modified "2023-10-16" @default.
• W2103459003 title "Organometallic Ruthenium(II) Diamine Anticancer Complexes: Arene-Nucleobase Stacking and Stereospecific Hydrogen-Bonding in Guanine Adducts" @default.
• W2103459003 cites W1935774199 @default.
• W2103459003 cites W1964155659 @default.
• W2103459003 cites W1966891700 @default.
• W2103459003 cites W1972459558 @default.
• W2103459003 cites W1973053405 @default.
• W2103459003 cites W1977233063 @default.
• W2103459003 cites W1979609931 @default.
• W2103459003 cites W1982204103 @default.
• W2103459003 cites W1982464755 @default.
• W2103459003 cites W1988338487 @default.
• W2103459003 cites W1988492767 @default.
• W2103459003 cites W1992630927 @default.
• W2103459003 cites W1994877946 @default.
• W2103459003 cites W2000510569 @default.
• W2103459003 cites W2004911739 @default.
• W2103459003 cites W2006456126 @default.
• W2103459003 cites W2014277122 @default.
• W2103459003 cites W2014588550 @default.
• W2103459003 cites W2020495161 @default.
• W2103459003 cites W2028338260 @default.
• W2103459003 cites W2030419816 @default.
• W2103459003 cites W2033993127 @default.
• W2103459003 cites W2036286319 @default.
• W2103459003 cites W2039478062 @default.
• W2103459003 cites W2042062103 @default.
• W2103459003 cites W2042246520 @default.
• W2103459003 cites W2043610941 @default.
• W2103459003 cites W2043721975 @default.
• W2103459003 cites W2044406876 @default.
• W2103459003 cites W2051941062 @default.
• W2103459003 cites W2053860395 @default.
• W2103459003 cites W2057049408 @default.
• W2103459003 cites W2058680666 @default.
• W2103459003 cites W2065120110 @default.
• W2103459003 cites W2069581738 @default.
• W2103459003 cites W2072557746 @default.
• W2103459003 cites W2079539223 @default.
• W2103459003 cites W2081696996 @default.
• W2103459003 cites W2085998505 @default.
• W2103459003 cites W2093500137 @default.
• W2103459003 cites W2129213133 @default.
• W2103459003 cites W2140591928 @default.
• W2103459003 cites W2231516589 @default.
• W2103459003 cites W2333249927 @default.
• W2103459003 cites W2415609548 @default.
• W2103459003 cites W2951441982 @default.
• W2103459003 cites W3004576110 @default.
• W2103459003 cites W3004747601 @default.
• W2103459003 cites W3005350944 @default.
• W2103459003 cites W304093823 @default.
• W2103459003 cites W4253991208 @default.
• W2103459003 cites W4255158849 @default.
• W2103459003 doi "https://doi.org/10.1021/ja017482e" @default.
• W2103459003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11902898" @default.
• W2103459003 hasPublicationYear "2002" @default.
• W2103459003 type Work @default.
• W2103459003 sameAs 2103459003 @default.
• W2103459003 citedByCount "405" @default.
• W2103459003 countsByYear W21034590032012 @default.
• W2103459003 countsByYear W21034590032013 @default.
• W2103459003 countsByYear W21034590032014 @default.
• W2103459003 countsByYear W21034590032015 @default.
• W2103459003 countsByYear W21034590032016 @default.
• W2103459003 countsByYear W21034590032017 @default.
• W2103459003 countsByYear W21034590032018 @default.
• W2103459003 countsByYear W21034590032019 @default.
• W2103459003 countsByYear W21034590032020 @default.
• W2103459003 countsByYear W21034590032021 @default.
• W2103459003 countsByYear W21034590032022 @default.
• W2103459003 countsByYear W21034590032023 @default.
• W2103459003 crossrefType "journal-article" @default.
• W2103459003 hasAuthorship W2103459003A5020864776 @default.
• W2103459003 hasAuthorship W2103459003A5050976890 @default.
• W2103459003 hasAuthorship W2103459003A5056323219 @default.
• W2103459003 hasAuthorship W2103459003A5060244445 @default.
• W2103459003 hasAuthorship W2103459003A5071855899 @default.
• W2103459003 hasAuthorship W2103459003A5088303429 @default.
• W2103459003 hasConcept C104317684 @default.
• W2103459003 hasConcept C108204754 @default.
• W2103459003 hasConcept C112887158 @default.
• W2103459003 hasConcept C115624301 @default.
• W2103459003 hasConcept C161790260 @default.
• W2103459003 hasConcept C178790620 @default.
• W2103459003 hasConcept C185592680 @default.
• W2103459003 hasConcept C2778301229 @default.
• W2103459003 hasConcept C32909587 @default.
• W2103459003 hasConcept C33347731 @default.

• next